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Abstract
Mutations in the elongation of very long chain fatty acid 4 (ELOVL4) gene cause Stargardt
macular dystrophy 3 (STGD3), a rare, juvenile-onset, autosomal dominant form of macular
degeneration. Although several mouse models have already been generated to investigate
the link between the three identified disease-causing mutations in the ELOVL4 gene, none
of these models recapitulates the early-onset cone photoreceptor cell death observed in the
macula of STGD3 patients. To address this specifically, we investigated the effect of mutant
ELOVL4 in a mouse model with an all-cone retina. Hence, we bred mice carrying the hetero-
zygously mutated Elovl4 gene on the R91W;Nrl-/- all-cone background and analyzed the ret-
inal lipid composition, morphology, and function over the course of 1 year. We observed a
reduction of total phosphatidylcholine-containing very long chain-polyunsaturated fatty
acids (PC-VLC-PUFAs) by 39% in the R91W;Nrl-/-;Elovl4 mice already at 6 weeks of age
with a pronounced decline of the longest forms of PC-VLC-PUFAs. Total levels of shorter-
chain fatty acids (< C26) remained unaffected. However, this reduction in PC-VLC-PUFA
content in the all-cone retina had no impact on morphology or function and did not acceler-
ate retinal degeneration in the R91W;Nrl-/-;Elovl4 mice. Taken together, mutations in the
ELOVL4 gene lead to cone degeneration in humans, whereas mouse models expressing
the mutant Elovl4 show predominant rod degeneration. The lack of a phenotype in the all-
cone retina expressing the mutant form of the protein supports the view that aberrant func-
tion of ELOVL4 is especially detrimental for rods in mice and suggests a more subtle role of
VLC-PUFAs for cone maintenance and survival.
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Introduction
Stargardt-3 (STGD3, OMIM #600110) is an early onset, autosomal dominant macular degen-
erative disease caused by mutations in the ELOVL4 that lead to C-terminal truncation of the
ELOVL4 protein [1–4]. As a macular dystrophy, STGD3 affects mostly cones, leads to loss of
central vision, decreased visual acuity and extensive formation of fundus flecks [5,6]. These
clinical features are similar to other maculopathies like Stargardt-1 (STGD1) [7] and age-
related macular degeneration (AMD) [8]. STGD3 discriminates from STGD1 by its autosomal
dominant inheritance and from AMD by its early onset within the first few decades of life
[5,6].
The ELOVL4 consists of 314 amino acids and has a 35% amino acid identity to yeast pro-
teins of the ELO family [9]. As part of the elongase multienzyme complex, it catalyzes the ini-
tial, rate-limiting condensation reaction of the cyclical process of elongating fatty acids (FA)
with 26 or more carbon atoms by adding two carbon-units to the acyl terminus per reaction
cycle [10–12]. The biosynthesis of very long chain fatty acid (VLC-FA; C28) synthesis takes
place in the endoplasmic reticulum (ER), where ELOVL4 is an integral membrane protein
with five predicted transmembrane domains, a distinct iron binding motif, and a C-terminal
di-lysine ER retention signal [1]. Three independent mutations in the last exon (exon 6) of the
ELOVL4 gene have been linked to STGD3 disease in humans [1,3,13,14]. These mutations do
not affect the catalytic domain but lead to loss of function due to mislocalization of the mutant
protein lacking the C-terminal ER retention signal [1,15]. In addition, mislocalized mutant
ELOVL4 protein has a dominant-negative effect on the localization of wild-type (wt) ELOVL4
potentially by protein aggregation [15–18].
ELOVL4 is primarily expressed in skin, testis, retina and brain where it elongates satu-
rated (skin and brain [19–21]) and polyunsaturated (retina and testis [22–24]) FA. Very long
chain saturated fatty acids (VLC-SFAs) and very long-chain poly unsaturated fatty acids
(VLC-PUFAs) do not exist as free FA, but rather have their carboxyl terminus linked to a
headgroup like e.g. glycerol or sphingosine to form lipids [12]. In the retina, VLC-PUFAs
form glycerolipids mostly associated with docosahexaenoic acid (22:6n3; DHA) in the sn-2
position and a polar phosphatidylcholine (PC) head group in sn-3 [25], whereas VLC-PUFAs
in the testis and VLC-SFA in the skin and brain mostly bind to sphingosine to form cer-
amides [19]. These ceramides are a hallmark for sperm capacitation [26] and play an impor-
tant role in maintaining skin barrier functions. Thus a global Elovl4 deletion or homozygous
expression of the STGD3 causing 5 base pair (5-bp) deletion mutation leads to dehydration
and neonatal lethality in mice due to lack of skin VLC-SFA that are necessary for mainte-
nance of skin barrier [19,20,27,28]. In the adult retina, the majority of ELOVL4 is expressed
in the photoreceptor (PR) cells. Only a minor portion can be found in ganglion cells
[10,14,29]. Conditional PR cell specific ablation of ELOVL4 reduces the VLC-PUFA content
of the retina by up to 98% without affecting retinal morphology or electrophysiological func-
tion [30]. Thus the function of the high levels of VLC-PUFAs in PR remains elusive. It has
been postulated that they may play a role in the maintenance of the highly curved edges of
the membrane disks of the PR outer segments (OS) by increasing membrane fluidity and
support during disk shedding [11,31,32]. On the other hand, mutations in ELOVL4, as found
in STGD3 patients, have been demonstrated to induce PR degeneration in mouse models
[30,33–36].
Despite significant attempts, none of the numerous transgenic, constitutive or conditional
knock-in and knock-out mouse models reproduced the early onset cone-degenerative pheno-
type of STGD3 patients successfully [9,20,30,33,35–38]. This may partially be based on the dif-
ficulty to analyze cone-dystrophies in the rod-dominant retina of mice.
Effect of Elovl4 mutation on all-cone retina
PLOS ONE | https://doi.org/10.1371/journal.pone.0190514 January 2, 2018 2 / 16
analysis, decision to publish, or preparation of the
manuscript.
Competing interests: The authors have declared
that no competing interests exist.
To analyze cone cell pathophysiology without interference of the rod system, we recently
generated a mutant mouse with an all-cone retina the Rpe65R91W;Nrl-/- (R91W;Nrl-/-) [39].
While the ablation of the neural leucine zipper protein (NRL) transcription factor directs PR
progenitors towards a cone cell fate [40], the R91W mutation in Rpe65 reduces the content of
11-cis-retinal in the retina and prevents rosette formation normally observed in Nrl-/- single
mutant mice [39]. The resulting all-cone retina of R91W;Nrl-/- is functional and has normal PR
layering making this mouse suitable to study the molecular mechanisms of cone degenera-
tions. In this study we thus investigated the effect of Elovl4 mutations on cone PR degeneration
by combining mice carrying the 5-bp deletion in Elovl4 [33] found in STGD3 patients with
R91W;Nrl-/- all-cone mice [39].
Material and methods
Animals
Mice were housed in the animal facility of the University of Zurich and maintained in a 14
hours light: 10 hours dark cycle with access to food and water ad libitum. Animal maintenance
and experimentation adhered to the regulations of the veterinary authorities of Kanton Zurich,
Switzerland and the ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research. The protocol was approved by the veterinary authorities of Kanton Zurich (license
nr. 109/2013 and 141/2016). The double mutant Rpe65R91W;Nrl-/- (R91W;Nrl-/-) all-cone
mouse line was previously generated by crossing Rpe65R91W (Rpe65tm1Lrcb, [41]) and Nrl-/-
(Nrltm1Asw, [40]) mutant strains, as described [39]. 129S6 (Taconic, Ejby, Denmark) and
C57BL/6J(Crl) (Charles River Laboratories, Lyon, France) mice were used as rod-dominant wt
controls.
The mouse harboring the 5-bp deletion (mouse790-794 del AACTT) in Elovl4 (Elovl4tm1Rayy,
[33]) was bred with the R91W;Nrl-/- mouse using classical breeding schemes. The resulting
R91W;Nrl-/-;Elovl4mut/wt mice were heterozygous for the 5-bp deletion in the Elovl4 gene and
will be referred to as “R91W;Nrl-/-;Elovl4mut” whereas littermates homozygous for the wt Elovl4
gene were used as controls and are referred to as “R91W;Nrl-/-“. Mice were genotyped by PCR
amplification of genomic DNA from ear biopsies by specific primer pairs for Rpe65R91W and
Nrl-/- as described earlier [39] and for Elovl4 (fwd:5’-GGCCCTGTAGGAGACTGTGA-3’; rev:
5’-CAAAGGGTGTCACTAAACACGGCA-3’).
Unless otherwise indicated, mice were euthanized by carbon dioxide asphyxiation before
tissue harvesting.
RNA isolation and semi-quantitative real-time PCR
Retinas were isolated through a slit in the cornea and snap frozen in liquid nitrogen. Total reti-
nal RNA was isolated using an RNA isolation kit (Nucleo Spin RNA, Macherey Nagel, Oensin-
gen, Switzerland) according to manufacturer’s instructions with an additional on-column
DNAseI treatment. One microgram of RNA was used for reverse transcription by oligo(dT)
and MMLV reverse transcriptase (Promega, Du¨bendorf, Switzerland). Semi-quantitative real-
time PCR (qPCR) was performed by a LightCycler480 instrument (Roche Diagnostics, Rotk-
reuz, Switzerland) on 10 ng cDNA template using SYBR Green I master mix (Roche Diagnos-
tics) and appropriate primer pairs (Table 1) designed to span large intronic regions and avoid
known SNPs. For the amplification of total Elovl4 transcripts (wt and mutant Elovl4), primers
annealed to exons 4 and 5, upstream of the 5-bp deletion. For the discrimination of wt and
mutant Elovl4, forward primer was designed in exon 5 and the reverse primer in the mutated
or wt region of exon 6. Thus, only the respective form of Elovl4 was amplified (Fig 1B).
Effect of Elovl4 mutation on all-cone retina
PLOS ONE | https://doi.org/10.1371/journal.pone.0190514 January 2, 2018 3 / 16
Reactions were normalized to β-Actin (Actb) and relative expression was calculated by the
comparative threshold cycle method (ΔΔCT). n = 3 for all time points.
Immunofluorescence
Mice were anesthetized with a lethal dose of ketamine/xylazine cocktail and transcardialy per-
fused with 4% (w/v) paraformaldehyde (PFA) prepared in phosphate buffer (0.1 M, pH 7.4).
Eyes were marked nasally, enucleated and processed for cryosectioning, as described earlier
[42]. Dorsoventral sections (12 μm) were blocked for 1 hour with 3% normal goat serum (con-
taining 0.3% Triton X-100 in PBS), and incubated overnight at 4˚C with rabbit anti-ELOVL4
antibody [11] (1:200), or A. hypogaea PNA-FITC (1:250, L7381, Sigma, Buchs, Switzerland).
After washing, slides were incubated with secondary anti-rabbit antibodies labeled with Cy3
Table 1. Primers for qPCR.
Gene Fwd 5’-3’ Rev 5’-3’
Total Elovl4 a) TTTTGTATCGAAAGGCGTTG AGGTATCGCTTCCACCAAAG
Wt Elovl4 a) TTTGGTGGAAGCGATACCTG ATGTCCGAGTGTAGAAGTTG
Mutant Elovl4 a) TTTGGTGGAAGCGATACCTG TGTATGTCCGAGTGTAGGAG
Gnat2 GCATCAGTGCTGAGGACAAA CTAGGCACTCTTCGGGTGAG
Arr3 CTGGCACTGGATGGCAAACT CCCCATAGGACACCACCAAG
Actb CAACGGCTCCGGCATGTGC CTCTTGCTCTGGGCCTCG
a) described in Vasireddy et al. [33]
https://doi.org/10.1371/journal.pone.0190514.t001
Fig 1. Evaluation of Elovl4 expression in the all-cone mice. (A) mRNA levels of total (left), mutant (middle) and wt (right) Elovl4 analyzed by semiquantitative real-
time PCR. Expression was normalized to Actb and expressed relative to 6-week-old R91W;Nrl-/- mice (left and right panel), or to 6-week-old R91W;Nrl-/-;Elovl4mut mice
(middle panel). n.d.: not detected. Shown are means ± SD. n = 3. : P< 0.001; : P< 0.0001. (B) Schematic representation of binding sites for primers used to
discriminate between total, wt and mutant Elovl4 transcripts (adapted from Vasireddy et al. [33]). (C) Western blot detection of indicated proteins in R91W;Nrl-/-;
Elovl4mut (mut), R91W;Nrl-/- (ctrl) and 129S6 (wt, rod-dominant) mice at 6, 12 and 24 weeks of age as indicated. Shown are representative blots of n = 3.
https://doi.org/10.1371/journal.pone.0190514.g001
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(Jackson ImmunoResearch Laboratories, Soham, UK), counterstained with 40,6-diamidino-
2-phenylindole (DAPI), and analyzed by fluorescence microscopy (Zeiss, Axioplan, Jena, Ger-
many). n = 3 for all time points.
Western blotting
Retinas were isolated through a slit in the cornea and homogenized by sonication in 200 μL of
100 mM Tris/HCl (pH 8,0). Homogenates were centrifuged and protein contents in the super-
natants determined using Bradford reagent (Bio-Rad, Hercules, CA, USA). SDS–PAGE and
Western blot analysis were performed as described earlier [42] using the following primary
antibodies: rabbit anti-C-terminus of ELOVL4 [11] (1:1’000), rabbit anti-cone photoreceptor
cGMP-gated channel subunit alpha (CNGA3) [43] (1:500) and mouse anti-ACTB (1:10’000,
A5441, Sigma). Immunoreactive signals were detected using the Western lightning chemilu-
minescence reagent (PerkinElmer, Waltham, MA, USA) and visualized using the Fusion FX
chemiluminescence & fluorescence imaging system (Vilber Lourmat; Colle´gien; France). n = 3
for all time points.
Retinal FA and phospholipid composition
Retinas were isolated through a slit in the cornea, snap frozen in liquid nitrogen and stored at
-80˚C until analysis. For FA profiles, total lipids were extracted following the method of Bligh
and Dyer [44] with modifications [45]. To each lipid extract 15:0 and 17:0 FAs were added as
internal standards. The lipid extracts were subjected to acid hydrolysis/methanolysis to gener-
ate fatty acid methyl esters (FAMEs) [46]. FAMEs were quantified using a gas chromatograph
(6890N, Agilent Technologies, Foster City, CA, United States) with flame ionization detector
(GC-FID) [47]. Data is represented as relative mole percent of each FA species. Additionally,
the retinal phospholipid composition was analyzed by methods described previously [21,48].
Briefly, retinas were homogenized in methanol and diluted 1:40 with 2-propanol/methanol/
chloroform (4:2:1 v/v/v) containing 20 mM ammonium formate and 1.00 μM PC 14:0/14:0,
1.00 μM phosphatidylethanolamine (PE) 14:0/14:0 and 0.33 μM phosphatidylserine (PS) 14:0/
14:0 as internal standards. Samples were introduced into a triple quadrupole mass spectrome-
ter (TSQ Ultra, Thermo Scientific, Waltham, MA, United States) using a chip-based nano-ESI
source (NanoMate, Advion, Ithaca, NY, United States) operating in infusion mode. PC lipids
were measured using precursor ion scanning of m/z 184, PE lipids were measured using neu-
tral loss scanning of m/z 141, and PS lipids were measured using neutral loss scanning of m/z
185. Quantification of lipid molecular species was performed using the Lipid Mass Spectrum
Analysis (LIMSA, University of Helsinki) software’s peak model fit algorithm. Data is repre-
sented as the relative percent of each measured species within each class (PC, PE, PS) ± stan-
dard deviation. n = 4 for all time points.
Morphology and nuclei count
Eyes were marked nasally, enucleated, fixed in glutaraldehyde (2.5% in cacodylate buffer)
overnight at 4˚C, trimmed, post-fixed in 1% osmium tetroxide and embedded in Epon 812
as described [42]. Dorsoventral semithin cross-sections of 0.5 μm were cut through the optic
nerve head, stained with toluidine blue and analyzed using light microscopy (Zeiss). Images of
higher magnifications were acquired from the central region close to the optic nerve head. PR
nuclei were counted manually in the region at 200–400 μm from the optic nerve head. n = 3
for all time points.
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Electroretinography
Electroretinograms (ERG) of 6- (n = 5), 12- (n = 6), 24- (n = 6), 38- (n = 4) and 52- (n = 3)
week old mice were recorded using an LKC UTAS Bigshot recording unit (LKC Technologies,
Inc. Gaithersburg, MD, USA) as previously described [49]. In brief: Mice were dark adapted
overnight and pupils dilated with Cyclogyl 1% (Alcon Pharmaceuticals, Fribourg, Switzerland)
and Neosynephrine 5% (Ursapharm Schweiz GmbH, Roggwil, Switzerland) 20 min before
recording. Mice were anesthetized by subcutaneous injection of Ketamine (85 mg/kg; Parke-
Davis, Berlin, Germany) and Xylazine (4 mg/kg Bayer AG, Leverkusen, Germany). The cornea
was kept moist with a drop of Mydriaticum dispersa (OmniVision AG, Neuhausen, Switzer-
land). Recording gold electrodes were placed directly onto the cornea of each eye, a reference
electrode was inserted under the skin between the eyes and a grounding electrode was posi-
tioned subcutaneously at the tail base. All manipulations were performed under dim red light.
ERG responses were recorded after adapting the eyes to low background light (30 cd × s × m-2)
for 5 min. Responses to single white light flashes with intensities ranging from -10 to 25 dB
(0.25 to 790 cd × s × m-2) divided in 8 steps were recorded with interstimulus intervals of either
5 seconds (for –10, –5, –0, and 5 dB), or 17 seconds (for 10, 15, 20, and 25 dB). Ten responses
per light intensity were averaged.
Statistical analysis
Statistical analysis was performed using Prism 6 software (GraphPad, San Diego, CA, USA).
All data are presented as mean values ± standard deviation (SD). The number of samples (n)
used for individual experiments is given in the methods section. Two-way ANOVA with
Holm-Sˇı´da´k correction for multiple comparisons was used to determine statistical signifi-
cance. P-values below 0.05 were considered significant (< 0.05: ;< 0.01: ; < 0.001: ;
< 0.0001: ).
Results
Expression of wt and mutant Elovl4 in the R91W;Nrl-/- retina
Cones are the most affected PR type in the retina of STGD3 patients. We thus investigated the
effects of a disease-linked Elovl4 mutation on cones using our R91W;Nrl-/- all-cone mouse
model. The R91W;Nrl-/-;Elovl4mut mouse was generated to express a wt and mutant copy of
Elovl4, mimicking the autosomal dominant inheritance of STGD3 macular degeneration in all
cone PR cells of R91W;Nrl-/- background. To detect potential differences in the expression of
wt or mutant Elovl4 mRNA, we compared retinal levels of Elovl4 transcripts between R91W;
Nrl-/-;Elovl4mut and R91W;Nrl-/- mice (Fig 1A and 1B). The total transcription levels (primer
pair recognizing both wt and mutant Elovl4) were similar between control and mutant mice,
indicating a continuous transcription of both forms of Elovl4. The general reduction of Elovl4
transcript levels in aged R91W;Nrl-/-;Elovl4mut and R91W;Nrl-/- mice was most likely due to the
slow intrinsic retinal degeneration in the R91W;Nrl-/- mouse itself [39]. This goes along with
the observed age-dependent decline of cone-specific transcript levels such as G protein subunit
alpha transducin 2 (Gnat2) and retinal cone arrestin-3 (Arr3), whereas expression of marker
genes for bipolar and ganglion cells did not decrease during the whole time course (S1 Fig). As
expected, the mutant Elovl4 transcript was detected exclusively in R91W;Nrl-/-;Elovl4mut mice
(Fig 1A, middle panel), whereas levels of the wt Elovl4 transcript were reduced at all time
points in mutant mice (Fig 1A, right panel).
Analysis of the ELOVL4 protein by Western blotting, using an antibody specific for C-ter-
minus, confirmed reduced levels of the wt ELOVL4 protein in R91W;Nrl-/-;Elovl4mut mice
Effect of Elovl4 mutation on all-cone retina
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compared to their respective controls throughout all time points. In contrast, signal intensities
for the cone-specific protein CNGA3 were similar in R91W;Nrl-/- (control) and R91W;Nrl-/-;
Elovl4mut mutant mice at individual time points (Fig 1C). However, as for ELOVL4, a reduc-
tion in CNGA3 signal was detected in both mouse models during ageing (Fig 1C).
Localization of ELOVL4 protein in the all-cone retina
ELOVL4 protein is highly expressed in the mouse retina and predominantly localized to the
ER of both rod and cone PR cells [14]. We detected strong staining in the outer nuclear layer
(ONL) and very weak signals in the inner nuclear layer (INL) and ganglion cell layer (GCL)
(Fig 2). Co-staining of ELOVL4 with PNA indicated the absence of ELOVL4 signal from the
OS of cones in mice of all genotypes (Fig 2). No major differences in tissue distribution of wt
ELOVL4 immunoreactivity was observed between R91W;Nrl-/-;Elovl4mut, control R91W;Nrl-/-
as well as C57BL/6J (wt) wild type mice. The overall staining intensity in the ONL, and occa-
sionally observed intense staining at the endfeeds of PR close to the outer plexiform layer
(OPL), was variable and could not be assigned to a specific genotype (Fig 2) or age group (not
shown).
Analysis of retinal FA composition
ELOVL4 catalyzes the rate limiting condensation reaction which is responsible for the elonga-
tion of saturated and poly-unsaturated C26 to C28 FA and is postulated as well to be the
responsible desaturase for all further elongation steps from C28 –C40 and beyond [11,18]. In
Fig 2. ELOVL4 distribution in R91W;Nrl-/-;Elovl4mut, R91W;Nrl-/- and C57BL/6J (wt) rod-dominant retina of 12-week-old mice. Red: ELOVL4; green: PNA (cone
PR segments); blue: DAPI. PRS: photoreceptor segments; ONL: outer nuclear layer; OPL: outer plexiform layer; INL: inner nuclear layer; IPL: inner plexiform layer;
GCL: ganglion cell layer. Scale bar: 50 μm. Shown are representative images of n = 3.
https://doi.org/10.1371/journal.pone.0190514.g002
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the retina, VLC-PUFAs form phospholipids by binding to the sn-1 position of PC, whereas
DHA is bound to sn-2 [12].
Expression of the mutant Elovl4 strongly affected the PC-VLC-PUFA composition already
in young animals. At 6 weeks of age, the total VLC-PUFAs of the PC fraction (28:4 to 36:6)
were reduced by 39% in R91W;Nrl-/-;Elovl4mut compared to corresponding all-cone control
mice (Fig 3A). This is in agreement with the reduced ELOVL4 protein and transcript levels
observed by Western blotting and qPCR, respectively. The reduction of PC-VLC-PUFAs in
R91W;Nrl-/-;Elovl4mut was most pronounced for the longest PUFAs (Fig 3B). For example,
while in 12-week-old R91W;Nrl-/-;Elovl4mut mice, the PC-54:11 (PC-22:6/32:5) showed only a
tendency to reduced levels when compared to R91W;Nrl-/- control mice, the PC-VLC-PUFAs
were reduced by 52% for the 56:11 (22:6/34:5) and by 75% for 58:11 (22:6/36:5). As expected,
since ELOVL4 is not involved in biosynthesis of C18—C24 fatty acids, mutation of one allele
of Elovl4 did not affect the composition of C18—C24 polyunsaturated FA, hence the levels
20:4n6, and 22:6n3 were not affected 6 (S1 Table). Also the omega-6:omega-3 (n3/n6) ratio of
PUFAs was comparable in the two mouse strains and did not change over time (Fig 3C).
Morphology and electroretinography
Based on the data presented for the original mouse model of STGD3 (Elovl4tm1Rayy, [33]), a
degenerative phenotype in R91W;Nrl-/-;Elovl4mut mice was expected. However, retinal mor-
phologies did not indicate accelerated degeneration in R91W;Nrl-/-;Elovl4mut mice (Fig 4).
Fig 3. Retinal FA composition. (A) Percentage of the sum of PC-VLC-PUFAs in the total PC pool at indicated ages. (B) All individually identified VLC-PUFAs of the
PC pool at indicated ages. The glycerolipids are composed of a PC headgroup, a DHA (22:6) and a VLC-PUFA (e.g.: PC-58:12 (22:6/36:6)) (C) Ratio of n6 to n3 FA in
total lipids at indicated ages. Shown are means ± SD (n = 4; : P< 0.05; : P< 0.0001).
https://doi.org/10.1371/journal.pone.0190514.g003
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None of the analyzed points (latest time point was 1 year of age), showed a qualitative (Fig 4A)
or quantitative (Fig 4B) difference in retinal thickness between the two strains.
Additionally, the light adapted, cone-driven ERG responses did not differ between R91W;
Nrl-/-;Elovl4mut and R91W;Nrl-/- mice and declined in both strains similarly in an age-depen-
dent manner (Fig 5A and 5B). This age-dependent loss of PR cells and decline in function is
Fig 4. Analysis of retinal morphology. (A) Representative micrographs of retinas from R91W;Nrl-/-;Elovl4mut and R91W;Nrl-/- mice at indicated ages. (B) Cone nuclei
count in the central retina. RPE: Retinal pigment epithelium, other abbreviations as in Fig 2. Red bars: R91W;Nrl-/-;Elovl4mut mice; blue bars: R91W;Nrl-/-. Scale bar:
20 μm. Shown are means ± SD (n = 3).
https://doi.org/10.1371/journal.pone.0190514.g004
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most likely caused by the intrinsic degeneration in the retina of all-cone mice, as described ear-
lier [39].
Discussion
Several mouse models have been generated to investigate the link between disease causing
mutations in the Elovl4 gene and macular degeneration that characterizes STGD3 pathophysi-
ology [33–35,37]. None of these models showed the early onset cone PR degeneration observed
in STGD3 patients but rather had rod PR cells affected. To examine the role of mutant Elovl4
in cone PR degeneration [5,6], we intercrossed the Elovl4 5-bp deletion knock-in mouse as a
model for STGD3 with the R91W;Nrl-/-strain which has an all-cone retina. The generated
cone-only R91W;Nrl-/-;Elovl4mut mouse carrying the human mutation should mimic the
human disease affecting the macular cones in STGD3 patients, allowing to study the effect of
mutant ELOVL4 protein specifically on cone function and survival.
Although the human ELOVL4 mutation leads to cone PR cell death and macular atrophy in
patients [5,6], the R91W;Nrl-/-;Elovl4mut mouse did not show the anticipated early onset retinal
degeneration. Both retinal function and morphology, analyzed up to one year of age, showed
Fig 5. Light-adapted ERG to test retinal function. (A) ERG traces of early (6 w), intermediate (24 w) and late (52 w) time points. (B) Photopic b-wave amplitudes
plotted against the logarithm of light intensities in R91W;Nrl-/-;Elovl4mut and control R91W;Nrl-/- mice at indicated ages. Shown are means ± SD (6 weeks, n = 5; 12
weeks, n = 6; 24 weeks, n = 6; 38 weeks, n = 4; and 52 weeks, n = 3).
https://doi.org/10.1371/journal.pone.0190514.g005
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no differences between the control and R91W;Nrl-/-;Elovl4mut mice, neither at early time points
nor in aged mice. This preservation of retinal morphology and function despite the presence
of mutant ELOVL4 was surprising, since rod-dominant transgenic mouse models indeed
showed signs of retinal degeneration [33–35]. Furthermore, the original mutant mouse
Elovl4tm1Rayy exhibited preferential loss of S-cones [33] which is the predominant type of cones
in the Nrl-/- [40] and R91W;Nrl-/- [39] mice. Therefore, the aggravated degeneration was
expected in the S-cone-rich retinas of R91W;Nrl-/-;Elovl4mut mice.
However, even though cones remained unaffected, the Elovl4 mutation clearly reduced lev-
els of mRNA transcript and ELOVL4 protein in R91W;Nrl-/-;Elovl4mut mice. Most importantly,
synthesis of VLC-PUFAs was severely diminished. Analysis of the PC-VLC-PUFA composi-
tion in the retina revealed reduction of the longest VLC-PUFAs already at early time points. E.
g. in 6-week-old R91W;Nrl-/-;Elovl4mut mice VLC-PUFAs—36:4, 36:5 and 36:6—were down to
19%, 29% and 42% of the controls, respectively. Yet, despite this early and substantial loss of
retinal VLC-PUFAs, cones were not discernably affected. The PC-VLC-PUFA fraction makes
1.6% of total PC in 6-week-old R91W;Nrl-/-. This amount is reduced to 1.0 mol % PC in the
age-matched R91W;Nrl-/-;Elovl4mut. When compared to data reported for the human macula
(0.2 mol % PC [50]) or for rod-dominant mouse retinas (2.3 mol % PC [50]) this means that
PC-VLC-PUFAs in the all-cone mice are reduced compared to rod-dominant mouse retinas,
but are also still much higher than in the human macula. It remains to be determined if the
plentiful reserves of VLC-PUFAs in R91W;Nrl-/-;Elovl4mut, and mice in general, might be
responsible for the lack of phenotypic characteristics of STGD3 macular dystrophy.
On the other hand, haploinsufficency [9] or even an almost complete PR specific depletion
of VLC-PUFAs does not induce PR degeneration [30,36]. Even though the two groups that
analyzed the effects of Elovl4 knock-down in the PR report somewhat conflicting results on
cone function [30,36], they present data consistent with preservation of cone morphology
upon near-total depletion of retinal VLC-PUFAs. This supports the concept that the mutant
ELOVL4 protein, and not the reduced VLC-PUFAs, is the driving force for the observed PR
degeneration in STGD3 patients and mouse models. It has been shown that mutant ELOVL4
mislocalizes to the outer segments of PR where it potentially induces PR cell death [51]. This
goes along with the observed positive correlation between expression levels of mutant
ELOVL4 and the severity of retinal degeneration in transgenic mouse models expressing
increasing amounts of the human mutant ELOVL4 protein (TG1, TG1-2, TG2 and TG3)
[34,35]. Yet, as VLC-PUFAs have been implicated in the maintenance of the structural and
functional integrity of retinal PRs [11,31,32], it remains a puzzle why cones in mouse models
do not follow the cone fate seen in STGD3 patients carrying the same mutation. It yet has to
be determined which specific genetic, physiological and / or environmental factors could be
responsible for the lack of human-like ELOVL4 effect on cone pathology in mice.
One trigger for cone degeneration in STGD might be lipofuscin-induced toxicity to the
RPE, as lipofuscin accumulation and RPE-atrophic lesions were observed in patients [52,53].
Lipofuscin, a predominant fundus fluorophore, accumulates in the RPE during the normal
ageing process. We have not observed signs of increased autofluorescence or changes in the
RPE of the R91W;Nrl-/-;Elovl4mut mice (not shown). The absence of lipofuscin accumulation
in R91W;Nrl-/-;Elovl4mut mice may not be surprising as the R91W mutation in RPE65 leads to
hypomorphic enzymatic function of RPE65 i.e. reduced regeneration of the visual pigment
[41]. A fully operational visual cycle, however, may be needed for the increased accumulation
of lipofuscin in the RPE, as RPE65 patients show reduced fundus autofluorescence and
Rpe65-/- mice reduced lipofuscin content [54–56]. In that respect, it would be interesting to
analyze the impact of Elovl4 mutations in rod dominant R91W or Rpe65-/- mutant mice. Of
special interest would be one of the mutant ELOVL4-overexpressing lines (TG2 or TG3, see
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above) which show a strong degeneration [34]. Monitoring retinal morphology in e.g. Rpe65-/-;
TG3 double mutant mice could help to answer the question if and to which extent lipofuscin
accumulation might contribute to PR degeneration in mice and STGD3 patients.
Another conceivable reason for cones being spared in mice and not in humans may be the
possibility that rod PRs in the parafoveal region of patients might be the first affected cells and
that foveal cones are perturbed only in turn as a consequence of defective rods in STGD3.
Although it still needs to be determined if defects in parafoveal rods could be a triggering
event for STGD3 maculopathy, work by Curcio and colleagues [57] demonstrated that this
may be the case for AMD. In AMD the pathological sequence of events starts with an initial
degeneration of parafoveal rods leading to loss of support for the neighboring foveal cones and
their degeneration, ultimately leading to deterioration of fine acuity vision. Such a scenario,
though possible in STG3 patients, cannot be easily tested in rod-dominant mouse models lack-
ing a macula, or for that matter, in all-cone mouse models lacking rods such as the R91W;Nrl-/-
mouse. The improvement of noninvasive imaging techniques, such as adaptive optics scanning
laser ophthalmoscopy may help to discern rod from cone structure and may allow to deter-
mine the state or rods and cones in patients in the near future. This will be instrumental for a
better understanding of the processes leading STGD3 disease.
Taken together, we report that the 5-bp deletion in Elovl4 reduces retinal VLC-PUFA con-
tent but does not affect cone PR morphology or function in R91W;Nrl-/-;Elovl4mut mice. As
haploinsufficency or near total depletion of VLC-PUFAs in rods or cones—as discussed above
[9,30,36]—has no impact on PR survival, this implies that i) VLC-PUFAs are dispensable for
PR function and maintenance and that ii) deleterious effects are mediated by the truncated
ELOVL4 protein directly. However, despite the presence of the mutation, the R91W;Nrl-/-;
Elovl4mut mice showed no sign of accelerated cone degeneration. Experiments on transgenic
mice expressing different amounts of the truncated ELOVL4 transgene imply that the degree
of degeneration might be directly proportional to expression levels of the mutant protein
[16,35]. Since both mice and STGD3 patients are heterozygous for ELOVL4, we hypothesize
that the human macula has either a higher turnover rate of ELOVL4 protein than the mouse
retina and/or is physiologically more sensitive to the presence of the mutant protein. High
metabolic demand, excessive oxygen consumption and exposure to light make the human
macula especially vulnerable to oxidative stress [58]. All of these factors may potentially
increase the burden on macular cones and, in combination with the truncated misguided
ELOVL4 protein, may be the crucial contributors to STGD3 pathology.
Supporting information
S1 Fig. Supplementary gene expression data analyzed by semiquantitative real-time PCR.
(A) mRNA levels of G protein subunit alpha transducin 2 (Gnat2), arrestin 3 (Arr3), POU
class 4 homeobox 1 (Pou4f1, alias: Brn3a), visual system homeobox 2 (Vsx2, alias: Chx10)
expressed relative to 6-week-old R91W;Nrl-/- mice. (B) mRNA levels of total (left) and wt
(right) Elovl4 in indicated strains expressed relative to 12-week-old R91W;Nrl-/- mice. Expres-
sion was normalized to Actb. Shown are means ± SD. n = 3.
(TIF)
S1 Table. Detailed results of retinal lipid and FA composition analysis. Phosphatidylcholine
composition (sheet: S1a_Table_PC), phosphatidylethanolamine composition (sheet: S1b_Table_
PE), phosphatidylserine composition (sheet: S1c_Table_PS), total lipid fatty acid composition
(sheet: S1d_Table_TL-FA) in retinas of R91W;Nrl-/-;Elovl4 and R91W;Nrl-/- mice. n = 4.
(XLSX)
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